MONTREAL, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results